HIGH-YIELD RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages mammalian cell lines for the generation of therapeutic antibodies. Chinese hamster ovary (CHO) cells emerged as a leading platform due to their productivity in producing complex, humanized antibodies. High-yield growth of CHO cells is crucial for economic viability and involves meticulous optimization of va